SCHEMBL4872157

SCHEMBL4872157

COc1cccc(C2(C(=O)NS(=O)(=O)c3ccc(C)cc3)CCN(c3ccccc3OC)CC2)c1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 2/20 0.51
ALDH1A1 P00352 3/20 0.49
HTT P42858 2/20 0.49
MAPT P10636 2/20 0.49
PKM P14618 1/20 0.49
SOAT1 P35610 5/20 0.48
HTR7 P34969 3/20 0.47
HTR1A P08908 2/20 0.47
HTR2A P28223 2/20 0.47
SLC6A4 P31645 1/20 0.47
HTR2B P41595 1/20 0.47
KCNH2 Q12809 1/20 0.47
MCOLN2 Q8IZK6 1/20 0.46
MCOLN3 Q8TDD5 1/20 0.46
MCOLN1 Q9GZU1 1/20 0.46
LMNA P02545 1/20 0.44
KDM4E B2RXH2 1/20 0.43
GAA P10253 1/20 0.43
TP53 P04637 1/20 0.43
POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4880002 0.88 SOAT1 (0.50) KMT2ASOAT1HTR1A
SCHEMBL4881102 0.87 SOAT1 (0.51) KMT2ASOAT1TP53POLB
SCHEMBL4876634 0.87 SOAT1 (0.52) KMT2ASOAT1HTR1A
Hydrochloric Acid SCHEMBL4880947 0.86 SOAT1 (0.51) KMT2AMAPTSOAT1
SCHEMBL4881317 0.83 SOAT1 (0.49) KMT2AMAPTSOAT1GAA
SCHEMBL4879927 0.83 SOAT1 (0.55) SOAT1
SCHEMBL4876840 0.82 SOAT1 (0.49) KMT2ASOAT1HTR1A
SCHEMBL4878421 0.82 SOAT1 (0.50) SOAT1HTR7KDM4E
SCHEMBL4878061 0.81 SOAT1 (0.58) KMT2AMAPTSOAT1HTR1A
SCHEMBL4868372 0.81 SOAT1 (0.57) ALDH1A1SOAT1HTR7HTR1AHTR2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080096922-A1 Novel Sulfonamide derivative DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) 2008-04-24 US disclosed
EP-1736467-A1 NOVEL SULFONAMIDE DERIVATIVE Dainippon Sumitomo Pharma Co., Ltd. (JP) 2006-12-27 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080096922-A1 Novel Sulfonamide derivative NR4A1, NR4A2, NR4A3 KMT2A 1132/4885ALDH1A1 2899/4885HTT 4561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.